BillionToOne (BLLN) EBT Margin (2024 - 2026)

BillionToOne (BLLN) posted EBT Margin of 17.08% for Q1 2026, up 160.48% sequentially from 6.56% in Q4 2025, and up 2367.0% YoY from 0.69% in Q1 2025.

BillionToOne (BLLN) EBT Margin (2024 - 2026) Analysis & Trends

BillionToOne has reported EBT Margin for 3 years, with the latest figure at 17.08% in Q1 2026.

Quarterly EBT Margin rose 2367.0% year-over-year to 17.08% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 7.64% (changed N/A YoY) and the FY2025 annual result came in at 2.54%, up 2977.0% from the prior year.
EBT Margin improved to 17.08% in Q1 2026 per BLLN's latest filing, from 6.56% in the prior quarter.
Over five years, EBT Margin peaked at 17.08% in Q1 2026 and troughed at 38.79% in Q3 2024.
A 3-year average of 6.75% and a median of 0.02% in 2025 frame the typical range for EBT Margin.
The sharpest annual moves came in 2025 and 2026: EBT Margin jumped 4548 bps in 2025, then jumped 2367 bps in 2026.
Over 3 years, EBT Margin stood at 25.41% in 2024, then surged by 126 bps to 6.56% in 2025, then soared by 160 bps to 17.08% in 2026.
According to Business Quant data, EBT Margin over the past three periods registered 17.08%, 6.56%, and 6.68% for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EBT Margin (Qtr)
1	Thermo Fisher Scientific	213.88 Bn	209.81 Bn	8.34 Bn	16.04%
2	Danaher	140.65 Bn	136.30 Bn	3.61 Bn	17.21%
3	Idexx Laboratories	46.02 Bn	45.83 Bn	779.09 Mn	34.29%
4	Agilent Technologies	39.85 Bn	38.05 Bn	990.00 Mn	22.23%
5	Iqvia Holdings	39.20 Bn	37.12 Bn	1.44 Bn	6.89%
6	Natera	38.80 Bn	37.70 Bn	696.04 Mn	-12.17%
7	Illumina	30.11 Bn	28.94 Bn	770.00 Mn	22.43%
8	Mettler Toledo International	28.66 Bn	28.61 Bn	650.22 Mn	28.17%
9	Quest Diagnostics	26.24 Bn	25.61 Bn	1.03 Bn	13.54%
10	BillionToOne	6.88 Bn	6.34 Bn	79.10 Mn	17.08%

Download Data